Literature DB >> 15897626

Newly designed primer sets available for evaluating various cytokines and iNOS mRNA expression in guinea pig lung tissues by RT-PCR.

Hiroyuki Yamada1, Tadashi Udagawa, Satoru Mizuno, Kumiko Hiramatsu, Isamu Sugawara.   

Abstract

Guinea pigs are often used as an animal model of human tuberculosis (TB). However, there are few methods available for pursuing the immunological processes involved in guinea pig TB. In this study, we developed for the first time systematic reverse transcription (RT)-PCR for evaluation of guinea pig mRNA expression. RT-PCR primer sets were newly designed for detection of cytokines and inducible nitric oxide synthase (iNOS) mRNA in guinea pig TB. Interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta, interleukin (IL)-1beta, IL-2, IL-10, IL-12p40, granulocyte-macrophage-colony stimulating factor (GM-CSF) and iNOS mRNA expression were detected significantly and reproducibly when these primer sets were used. The data by real-time PCR were comparable with those of RT-PCR. We showed that these RT-PCR primer sets could be used to examine mRNA expression semi-quantitatively in guinea pig tissues, and conclude that these newly designed primer sets for conventional RT-PCR will be useful for studying the immunological processes in guinea pig tuberculosis experiments to investigate and evaluate efficacy of new vaccines or anti-mycobacterial drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897626     DOI: 10.1538/expanim.54.163

Source DB:  PubMed          Journal:  Exp Anim        ISSN: 0007-5124


  12 in total

1.  Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination.

Authors:  Julia A Tree; Michael J Elmore; Sajid Javed; Ann Williams; Philip D Marsh
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

2.  Retinoic acid therapy attenuates the severity of tuberculosis while altering lymphocyte and macrophage numbers and cytokine expression in rats infected with Mycobacterium tuberculosis.

Authors:  Hiroyuki Yamada; Satoru Mizuno; A Catharine Ross; Isamu Sugawara
Journal:  J Nutr       Date:  2007-12       Impact factor: 4.798

3.  Cytokine profiles in primary and secondary pulmonary granulomas of Guinea pigs with tuberculosis.

Authors:  Lan H Ly; Murat I Russell; David N McMurray
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11-21       Impact factor: 6.914

4.  Kinetics of the immune response profile in guinea pigs after vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.

Authors:  Ajay Grover; Jennifer Taylor; JoLynn Troudt; Andrew Keyser; Kimberly Arnett; Linda Izzo; Drew Rholl; Angelo Izzo
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

Review 5.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410

Review 6.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

Review 7.  The guinea pig model for tick-borne spotted fever rickettsioses: A second look.

Authors:  John V Stokes; David H Walker; Andrea S Varela-Stokes
Journal:  Ticks Tick Borne Dis       Date:  2020-08-07       Impact factor: 3.744

8.  Latency antigen α-crystallin based vaccination imparts a robust protection against TB by modulating the dynamics of pulmonary cytokines.

Authors:  Bappaditya Dey; Ruchi Jain; Aparna Khera; Umesh D Gupta; V M Katoch; V D Ramanathan; Anil K Tyagi
Journal:  PLoS One       Date:  2011-04-18       Impact factor: 3.240

9.  Efficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lung.

Authors:  Ankan Gupta; Farhan J Ahmad; Faiz Ahmad; Umesh D Gupta; Mohan Natarajan; Vishwamohan Katoch; Sangeeta Bhaskar
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

10.  Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung.

Authors:  Ruchi Jain; Bappaditya Dey; Neeraj Dhar; Vivek Rao; Ramandeep Singh; Umesh D Gupta; V M Katoch; V D Ramanathan; Anil K Tyagi
Journal:  PLoS One       Date:  2008-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.